INSTITUT CURIE_Site Paris

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Metastatic breast cancer3 trials
• Childhood cancers1 trial
• Ovarian cancer1 trial
• Triple-negative breast cancer1 trial

Phase

• Phase 32 trials
• Phase 41 trial

Status

• Active, not recruiting2 trials
• Completed2 trials
• Recruiting2 trials

Lead sponsor

• Institut Curie2 trials
• AGO Research GmbH1 trial
• Alliance Foundation Trials, LLC.1 trial
• Institut Claudius Regaud1 trial
• UNICANCER1 trial

Running trials

• Recruiting

  Study Aiming to Compare the Plasma Exposure of the Payload (Free-DXd) in Patients Treated by T-DXd for Locally Advanced or Metastatic Breast Cancer According to Their BMI.

  NCT07195344· Phase 4· Institut Claudius Regaud· Source

  Contact: Audrey Bellesoeur, MD

• Recruiting

  68Ga-FAPI-46 PET/CT for Predicting Histological Response in Triple-negative Breast Cancer (FAP-IT)

  NCT06349512· Institut Curie· Source

  Contact: Nina JEHANNO, MD

• Active, not recruiting

  Locoregional Treatment and Palbociclib in de Novo, Treatment Naive, Stage IV ER+, HER2- Breast Cancer Patients

  NCT03870919· UNICANCER· Source

• Active, not recruiting

  Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer

  NCT02947685· Phase 3· Alliance Foundation Trials, LLC.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Metastatic breast cancer1 recruiting
• Triple-negative breast cancer1 recruiting

Closed trials

• Completed

  Impact of Sick Peer Relation on Adaptation to Disease and on Treatment of Cancer-suffering Adolescents & Young Adults

  NCT03964116· Institut Curie· Source

• Completed

  Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer

  NCT03353831· Phase 3· AGO Research GmbH· Source